Beximco Pharmaceuticals Ltd.
BXP | IL
Overview
Corporate Details
- ISIN(s):
- US0885792061
- LEI:
- 213800IMBBD6TIOQGB56
- Country:
- Bangladesh
- Address:
- N/A
- Website:
- https://www.beximcopharma.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 17:10 |
Report Publication Announcement
Request of Extension to Publish Q1 Results
|
English | 11.2 KB | ||
| 2025-11-04 08:25 |
Regulatory Filings
Change of Name to Beximco Pharmaceuticals PLC.
|
English | 10.8 KB | ||
| 2025-10-27 16:53 |
Report Publication Announcement
Request of Extension to Publish Financial Results
|
English | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all Beximco Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Beximco Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beximco Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan
4883
Japan
4883
Pioneering mRNA science to create transformative medicines and vaccines for diverse diseases.
United States of America
MRNA
United States of America
MRNA
Pioneering DARPin protein drugs for complex diseases in oncology and virology.
Switzerland
MOLN
Switzerland
MOLN
Developing therapies for hard-to-treat tumors (like AML) and viruses.
United States of America
MBRX
United States of America
MBRX
Develops molecular glue degraders to target undruggable proteins in cancer and immune diseases.
United States of America
GLUE
United States of America
GLUE
South Korea
322970
Developing Nanobody therapies for inflammatory and immunologic diseases like psoriatic arthritis.
United States of America
MLTX
United States of America
MLTX
Manufactures health products and provides OEM/ODM services using advanced encapsulation technology.
Japan
4524
Japan
4524
Biopharma company creating antibody therapies for oncology, with a focus on blood cancers.
Germany
MOR
Germany
MOR
Developing CAR T-cell and gene therapies for cancers and rare genetic disorders.
United States of America
MBIO
United States of America
MBIO